73:
995:
346:
excellence within the NHS and strengthening professional leadership. The consultant pharmacist posts have been created to provide a dynamic link between clinical practice and service development to support new models for delivering patient care. The title consultant pharmacist should only apply to approved posts that meet the principles, set out in the guidance, around four main functions:
136:
32:
299:
Pharmaceutical
Society of Australia, Society of Hospital Pharmacists Australia and the Australian College of Pharmacy (owned by the Queensland branch of the Pharmacy Guild of Australia) are now the three organisations that provide credentialing for pharmacists to be able to undertake domiciliary medication management reviews.
370:
The competency requirements for consultant pharmacists are drawn from the
Advanced and Consultant Level Competency Framework designed by the Competency Development and Evaluation Group (CoDEG, see www.codeg.org) which is divided into six capability (competency) clusters. Postholders are required to
326:
The demand for consultant pharmacists is on the rise. Licensing and accrediting agencies such as
Centers for Medicare and Medicaid (CMS), Accreditation Association for Ambulatory Health Care (AAAHC), The Joint Commission (JC) and individual states licensing bodies encourage healthcare facilities to
366:
The guidance recommends that the title consultant pharmacist is not conferred on individuals purely in recognition of innovative or excellent practice, but for those practitioners who meet the required competencies for the post. In the NHS, the posts created within or across NHS organisations, are
361:
Professional leadership. Consultant pharmacists will develop and identify best practice working with advanced practitioners, professional managers of pharmaceutical services, and other relevant healthcare professionals to achieve successful outcomes. They will be acknowledged sources of expertise,
302:
The
Australian Pharmacy Council will develop Aged Care Accreditation Standards in 2023 for pharmacists working in residential aged care settings and undertaking medication management reviews. These standards are being developed in response to a series of research papers published by the Consultant
298:
These pharmacists undergo a credentialing process, that was historically referred to as accreditation, and were then able to access the funding to perform these roles. The major accreditation organisation, known as the
Australian Association of Consultant Pharmacy, was disbanded in 2022. The
345:
The
Department of Health for England produced guidance in 2005 which described the role of the Consultant Pharmacist which is distinct from other roles in England and internationally. The posts are intended to be innovative new posts that will help improve patient care by retaining clinical
387:
There is work is underway to make explicit links between the
Competency Framework and the NHS Knowledge and Skills Framework. The role of consultant pharmacists in the NHS is evolving and although many posts are currently based in hospital practice, the role is developing in primary care.
367:
approved by
Strategic Health Authorities (or clusters of SHA’s). The SHA's provide approval panels for ratification of consultants posts to ensure that business plans match the spirit of this guidance and that posts are sustainable, equitable and transferable across the NHS.
357:
Education, mentoring and overview of practice, with a clear role in working with higher education institutions (HEIs), undertaking teaching in their field of practice and work to enhance links between practice, professional bodies and
274:
providing expert advice on clinical pharmacy, academic pharmacy or practice, public health pharmacy, industrial pharmacy, community pharmacy or practice, pharmaceutical analysis etc., regarding the safe use and production of
353:
Research, evaluation and service development, playing a crucial role in addressing the need to increase research capacity and to develop a workforce that is research aware as well as contributing to audit and service
350:
Expert practice, ensuring that the highest level of pharmaceutical expertise is available to those patients who need it and making the best use of high level pharmacy skills in patient care.
303:
Pharmacists' Services
Research Network (COHERENT) that has found inconsistencies in the delivery of these services and the preparedness of pharmacists generally to move into these settings.
291:
In
Australia, a consultant pharmacist has historically referred to a pharmacist accredited to access funding to be remunerated for providing Residential Medication Management Reviews and
342:, the term consultant pharmacist refers to a pharmacist who has advanced roles in patient care, research and education in a specific medical speciality or expert area of practice.
383:
A majority of the competencies in each of the management, education, training and development and research & evaluation clusters at the intermediate level (excellence).
83:
397:
456:"Factors influencing pharmacist interest and preparedness to work as on-site aged care pharmacists: insights from qualitative analysis of free-text survey responses"
319:. Consultant pharmacists ensure their patients’ medications are appropriate, effective, as safe as possible and used correctly; and identify, resolve, and prevent
375:
A majority of competencies in each of the expert professional practice, building working relationships and leadership clusters at the highest level (mastery)
628:
427:
20:
978:
735:
45:
160:
of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be
566:"What types of information do pharmacists include in comprehensive medication management review reports? A qualitative content analysis"
675:
422:
292:
249:
231:
212:
117:
59:
184:
1024:
953:
157:
1029:
973:
191:
511:"Clinical pharmacists' reported approaches and processes for undertaking Home Medicines Review services: A national survey"
153:
629:
https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Reports/downloads/lewingroup.pdf
198:
169:
948:
564:
Al-Diery, Tarik; Freeman, Hollie; Page, Amy Theresa; Cross, Amanda J.; Hawthorne, Deborah; Lee, Kenneth (2023-03-17).
99:
362:
and will contribute to the development of service strategies, which will drive change across health and social care.
283:
to medical institutions, hospitals, universities, research institutions, medical practices and individual patients.
95:
51:
180:
943:
784:
509:
Lee, Kenneth; Kouladjian O'Donnell, Lisa; Cross, Amanda J; Hawthorne, Deborah; Page, Amy Theresa (2023-06-01).
925:
339:
146:
668:
454:
Cross, Amanda J; Hawthorne, Deborah; Lee, Kenneth; O'Donnell, Lisa Kouladjian; Page, Amy T (2023-02-23).
900:
320:
330:
Consultants may specialize in one of the following areas: Regulatory, Quality, Technical, or Clinical.
165:
510:
455:
968:
905:
799:
708:
161:
915:
847:
830:
809:
730:
703:
402:
205:
910:
873:
842:
611:
546:
491:
311:
In the US, a consultant pharmacist focuses on reviewing and managing the medication regimens of
1019:
998:
963:
890:
868:
804:
720:
661:
603:
585:
538:
530:
483:
475:
958:
933:
895:
772:
760:
756:
593:
577:
522:
467:
432:
878:
852:
765:
598:
938:
837:
1013:
794:
789:
615:
550:
495:
751:
316:
526:
471:
698:
276:
581:
825:
777:
715:
271:
267:
589:
565:
534:
479:
607:
542:
487:
725:
684:
280:
312:
19:
This article is about the profession. For the medical journal, see
152:
Please help to demonstrate the notability of the topic by citing
657:
129:
82:
deal primarily with the United Kingdom and do not represent a
66:
25:
653:
648:
643:
315:, particularly those in institutional settings such as
91:
924:
861:
818:
744:
691:
398:Classification of Pharmaco-Therapeutic Referrals
323:that may interfere with the goals of therapy.
669:
649:Australian Association of Consultant Pharmacy
80:The examples and perspective in this article
8:
60:Learn how and when to remove these messages
676:
662:
654:
644:American Society of Consultant Pharmacists
570:International Journal of Clinical Pharmacy
428:American Society of Consultant Pharmacists
21:American Society of Consultant Pharmacists
597:
250:Learn how and when to remove this message
232:Learn how and when to remove this message
118:Learn how and when to remove this message
736:Separation of prescribing and dispensing
16:Provider of expert pharmaceutical advice
414:
515:Archives of Gerontology and Geriatrics
460:Archives of Gerontology and Geriatrics
7:
423:"What is a Consultant Pharmacist?"
14:
41:This article has multiple issues.
994:
993:
954:List of pharmaceutical companies
134:
71:
30:
974:Pharmacies in the United States
145:may not meet Knowledge (XXG)'s
49:or discuss these issues on the
1:
527:10.1016/j.archger.2023.104965
472:10.1016/j.archger.2023.104971
327:use consultant pharmacists.
147:general notability guideline
949:Pharmacy benefit management
321:medication-related problems
94:, discuss the issue on the
1046:
582:10.1007/s11096-023-01561-5
154:reliable secondary sources
143:The topic of this article
18:
989:
944:Investigational New Drug
785:Pharmaceutical chemistry
731:Pharmacological activity
1025:Health care occupations
926:Pharmaceutical industry
745:Pharmaceutical sciences
293:Home Medication Reviews
281:pharmaceutical services
279:or on the provision of
181:"Consultant pharmacist"
1030:Consulting occupations
901:Pharmacist prescriber
886:Consultant pharmacist
264:consultant pharmacist
969:Pharmacies of Norway
906:Pharmacy informatics
800:Pharmacoepidemiology
709:Prehistoric medicine
100:create a new article
92:improve this article
916:Veterinary pharmacy
848:Pharmacy technician
810:Pharmacocybernetics
704:History of pharmacy
403:History of pharmacy
911:Specialty pharmacy
874:Community pharmacy
843:Pharmacy residency
149:
1007:
1006:
964:Pharmacy in China
891:Hospital pharmacy
869:Clinical pharmacy
805:Pharmacovigilance
721:Prescription drug
260:
259:
252:
242:
241:
234:
216:
144:
128:
127:
120:
102:, as appropriate.
64:
1037:
997:
996:
959:Medication costs
934:Drug development
896:Nuclear pharmacy
773:Pharmacogenomics
761:Pharmacodynamics
757:Pharmacokinetics
678:
671:
664:
655:
631:
626:
620:
619:
601:
561:
555:
554:
506:
500:
499:
451:
445:
444:
442:
440:
431:. Archived from
419:
255:
248:
237:
230:
226:
223:
217:
215:
174:
138:
137:
130:
123:
116:
112:
109:
103:
75:
74:
67:
56:
34:
33:
26:
1045:
1044:
1040:
1039:
1038:
1036:
1035:
1034:
1010:
1009:
1008:
1003:
985:
920:
857:
853:Pharmacy school
814:
766:Pharmacometrics
740:
687:
682:
640:
635:
634:
627:
623:
563:
562:
558:
508:
507:
503:
453:
452:
448:
438:
436:
435:on 2 April 2015
421:
420:
416:
411:
394:
336:
309:
289:
270:who works as a
256:
245:
244:
243:
238:
227:
221:
218:
175:
173:
151:
139:
135:
124:
113:
107:
104:
89:
76:
72:
35:
31:
24:
17:
12:
11:
5:
1043:
1041:
1033:
1032:
1027:
1022:
1012:
1011:
1005:
1004:
1002:
1001:
990:
987:
986:
984:
983:
982:
981:
971:
966:
961:
956:
951:
946:
941:
939:Drug discovery
936:
930:
928:
922:
921:
919:
918:
913:
908:
903:
898:
893:
888:
883:
882:
881:
871:
865:
863:
862:Practice areas
859:
858:
856:
855:
850:
845:
840:
838:Pharmaconomist
835:
834:
833:
822:
820:
816:
815:
813:
812:
807:
802:
797:
792:
787:
782:
781:
780:
775:
770:
769:
768:
748:
746:
742:
741:
739:
738:
733:
728:
723:
718:
713:
712:
711:
701:
695:
693:
689:
688:
683:
681:
680:
673:
666:
658:
652:
651:
646:
639:
638:External links
636:
633:
632:
621:
576:(3): 712–721.
556:
501:
446:
413:
412:
410:
407:
406:
405:
400:
393:
390:
385:
384:
377:
376:
364:
363:
359:
355:
351:
335:
334:United Kingdom
332:
308:
305:
288:
285:
258:
257:
240:
239:
142:
140:
133:
126:
125:
86:of the subject
84:worldwide view
79:
77:
70:
65:
39:
38:
36:
29:
15:
13:
10:
9:
6:
4:
3:
2:
1042:
1031:
1028:
1026:
1023:
1021:
1018:
1017:
1015:
1000:
992:
991:
988:
980:
977:
976:
975:
972:
970:
967:
965:
962:
960:
957:
955:
952:
950:
947:
945:
942:
940:
937:
935:
932:
931:
929:
927:
923:
917:
914:
912:
909:
907:
904:
902:
899:
897:
894:
892:
889:
887:
884:
880:
877:
876:
875:
872:
870:
867:
866:
864:
860:
854:
851:
849:
846:
844:
841:
839:
836:
832:
829:
828:
827:
824:
823:
821:
817:
811:
808:
806:
803:
801:
798:
796:
795:Pharmacognosy
793:
791:
790:Pharmaceutics
788:
786:
783:
779:
776:
774:
771:
767:
764:
763:
762:
758:
755:
754:
753:
750:
749:
747:
743:
737:
734:
732:
729:
727:
724:
722:
719:
717:
714:
710:
707:
706:
705:
702:
700:
697:
696:
694:
690:
686:
679:
674:
672:
667:
665:
660:
659:
656:
650:
647:
645:
642:
641:
637:
630:
625:
622:
617:
613:
609:
605:
600:
595:
591:
587:
583:
579:
575:
571:
567:
560:
557:
552:
548:
544:
540:
536:
532:
528:
524:
520:
516:
512:
505:
502:
497:
493:
489:
485:
481:
477:
473:
469:
465:
461:
457:
450:
447:
434:
430:
429:
424:
418:
415:
408:
404:
401:
399:
396:
395:
391:
389:
382:
381:
380:
374:
373:
372:
371:demonstrate:
368:
360:
356:
352:
349:
348:
347:
343:
341:
333:
331:
328:
324:
322:
318:
317:nursing homes
314:
307:United States
306:
304:
300:
296:
294:
286:
284:
282:
278:
273:
269:
265:
254:
251:
236:
233:
225:
214:
211:
207:
204:
200:
197:
193:
190:
186:
183: –
182:
178:
177:Find sources:
171:
167:
163:
159:
155:
148:
141:
132:
131:
122:
119:
111:
108:December 2010
101:
97:
93:
87:
85:
78:
69:
68:
63:
61:
54:
53:
48:
47:
42:
37:
28:
27:
22:
885:
752:Pharmacology
624:
573:
569:
559:
518:
514:
504:
463:
459:
449:
437:. Retrieved
433:the original
426:
417:
386:
378:
369:
365:
344:
338:In the UK's
337:
329:
325:
310:
301:
297:
290:
263:
261:
246:
228:
219:
209:
202:
195:
188:
176:
114:
105:
81:
57:
50:
44:
43:Please help
40:
819:Professions
699:Compounding
354:evaluation.
277:medications
158:independent
1014:Categories
826:Pharmacist
778:Toxicology
716:Medication
521:: 104965.
466:: 104971.
409:References
272:consultant
268:pharmacist
192:newspapers
166:redirected
46:improve it
616:257604163
590:2210-7711
551:256968653
535:0167-4943
496:257173383
480:0167-4943
287:Australia
156:that are
96:talk page
52:talk page
1020:Pharmacy
999:Category
726:Pharmacy
685:Pharmacy
608:36932315
599:10250515
543:36821873
488:36842404
439:11 March
392:See also
313:patients
222:May 2017
90:You may
979:History
692:General
206:scholar
170:deleted
759:&
614:
606:
596:
588:
549:
541:
533:
494:
486:
478:
208:
201:
194:
187:
179:
162:merged
612:S2CID
547:S2CID
492:S2CID
358:HEIs.
266:is a
213:JSTOR
199:books
168:, or
98:, or
879:shop
831:List
604:PMID
586:ISSN
539:PMID
531:ISSN
484:PMID
476:ISSN
441:2015
379:and
185:news
594:PMC
578:doi
523:doi
519:109
468:doi
464:110
340:NHS
295:.
1016::
610:.
602:.
592:.
584:.
574:45
572:.
568:.
545:.
537:.
529:.
517:.
513:.
490:.
482:.
474:.
462:.
458:.
425:.
262:A
164:,
55:.
677:e
670:t
663:v
618:.
580::
553:.
525::
498:.
470::
443:.
253:)
247:(
235:)
229:(
224:)
220:(
210:·
203:·
196:·
189:·
172:.
150:.
121:)
115:(
110:)
106:(
88:.
62:)
58:(
23:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.